In breast cancer patients (n = 421) whose cancers have high levels of MYC mRNA expression, concurrent high expression of both MYC and MTBP mRNA conferred worse survival compared to those with high MYC and low MTBP expression (p = 0.0314) [4]. The gene discussed is MTBP; the disease is cancer.